Exact Mass: 527.185
Exact Mass Matches: 527.185
Found 489 metabolites which its exact mass value is equals to given mass value 527.185
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Daunorubicin
Daunorubicin is only found in individuals that have used or taken this drug. It is a very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms. [PubChem]Daunorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Daunorubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors KEIO_ID D106
Hygromycin B
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp
An O(4)-glycosyl-L-hydroxyproline that is cis-L-hydroxylproline glycosylated by a beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf moiety
Hygromycin B
Hygromycin B is a fda approved antibiotic food additive for swine and poultry Hygromycin B is an antibiotic produced by the bacterium Streptomyces hygroscopicus. It is an aminoglycoside that kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis. In the laboratory it is used for the selection and maintenance of prokaryotic and eukaryotic cells that contain the hygromycin resistance gene. The resistance gene is a kinase that inactivates hygromycin B through phosphorylation. Since the discovery of hygromycin-resistance genes, hygromycin B has become a standard selection antibiotic in gene transfer experiments in many prokaryotic and eukaryotic cells D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents FDA approved antibiotic food additive for swine and poultry Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
Gliquidone
Gliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is an ATP-dependent K+ (KATP) channel blocker. This block causes a depolarization which leads to activation of voltage-dependent Ca channels and Ca2+ influx, and eventually increases insulin release. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents
Rolitetracycline
Rolitetracycline is only found in individuals that have used or taken this drug. It is a pyrrolidinylmethyl tetracycline.Rolitetracycline is a semisynthetic broad-spectrum tetracycline antibiotic used especially for parenteral administration in cases requiring high concentrations or when oral administration is impractical. Rolitetracycline passively diffuses through porin channels in the bacterial membrane and reversibly binds to the 30S ribosomal subunit, preventing binding of tRNA to the mRNA-ribosome complex, and thus interfering with protein synthesis. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Lumefantrine
Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with artemether for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
5-Carboxytetramethylrhodamine succinimidyl ester
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines
2-(Dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
Esorubicin
D000970 - Antineoplastic Agents
N-Demethylmenogaril
Cerubidin
(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-N-(pyrrolidin-1-ylmethyl)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
(2,6-epoxy-1,2alpha,3beta,4alpha,5alpha-pentahydroxy)hexane-(1->6)-5,6-dihydrochelerythrine|maclekarpine D
His Gln Glu Asp
Daunorubicin
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent A natural product found in Actinomadura roseola. D004791 - Enzyme Inhibitors
Rolitetracycline
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines A derivative of tetracycline in which the amide function is substituted with a pyrrolidinomethyl group. C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Gliquidone
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents
Ala Asp His Trp
Ala Asp Trp His
Ala His Asp Trp
Ala His Trp Asp
Ala Trp Asp His
Ala Trp His Asp
Cys Cys Phe Arg
Cys Cys Arg Phe
Cys Asp Lys Tyr
Cys Asp Gln Tyr
Cys Asp Tyr Lys
Cys Asp Tyr Gln
Cys Glu Asn Tyr
Cys Glu Tyr Asn
Cys Phe Cys Arg
Cys Phe Lys Met
Cys Phe Met Lys
Cys Phe Met Gln
Cys Phe Gln Met
Cys Phe Arg Cys
Cys Gly Trp Tyr
Cys Gly Tyr Trp
Cys Lys Asp Tyr
Cys Lys Phe Met
Cys Lys Met Phe
Cys Lys Tyr Asp
Cys Met Phe Lys
Cys Met Phe Gln
Cys Met Lys Phe
Cys Met Gln Phe
Cys Asn Glu Tyr
Cys Asn Tyr Glu
Cys Gln Asp Tyr
Cys Gln Phe Met
Cys Gln Met Phe
Cys Gln Tyr Asp
Cys Arg Cys Phe
Cys Arg Phe Cys
Cys Arg Ser Tyr
Cys Arg Tyr Ser
Cys Ser Arg Tyr
Cys Ser Tyr Arg
Cys Trp Gly Tyr
Cys Trp Tyr Gly
Cys Tyr Asp Lys
Cys Tyr Asp Gln
Cys Tyr Glu Asn
Cys Tyr Gly Trp
Cys Tyr Lys Asp
Cys Tyr Asn Glu
Cys Tyr Gln Asp
Cys Tyr Arg Ser
Cys Tyr Ser Arg
Cys Tyr Trp Gly
Asp Ala His Trp
Asp Ala Trp His
Asp Cys Lys Tyr
Asp Cys Gln Tyr
Asp Cys Tyr Lys
Asp Cys Tyr Gln
Asp Glu His Lys
Asp Glu His Gln
Asp Glu Lys His
Asp Glu Gln His
Asp His Ala Trp
Asp His Glu Lys
Asp His Glu Gln
Asp His Lys Glu
Asp His Gln Glu
Asp His Trp Ala
Asp Lys Cys Tyr
Asp Lys Glu His
Asp Lys His Glu
Asp Lys Tyr Cys
Asp Gln Cys Tyr
Asp Gln Glu His
Asp Gln His Glu
Asp Gln Tyr Cys
Asp Trp Ala His
Asp Trp His Ala
Asp Tyr Cys Lys
Asp Tyr Cys Gln
Asp Tyr Lys Cys
Asp Tyr Gln Cys
Glu Cys Asn Tyr
Glu Cys Tyr Asn
Glu Asp His Lys
Glu Asp His Gln
Glu Asp Lys His
Glu Asp Gln His
Glu Glu His Asn
Glu Glu Asn His
Glu Gly His Trp
Glu Gly Trp His
Glu His Asp Lys
Glu His Asp Gln
Glu His Glu Asn
Glu His Gly Trp
Glu His Lys Asp
Glu His Asn Glu
Glu His Gln Asp
Glu His Trp Gly
Glu Lys Asp His
Glu Lys His Asp
Glu Asn Cys Tyr
Glu Asn Glu His
Glu Asn His Glu
Glu Asn Tyr Cys
Glu Gln Asp His
Glu Gln His Asp
Glu Trp Gly His
Glu Trp His Gly
Glu Tyr Cys Asn
Glu Tyr Asn Cys
Phe Cys Cys Arg
Phe Cys Lys Met
Phe Cys Met Lys
Phe Cys Met Gln
Phe Cys Gln Met
Phe Cys Arg Cys
Phe Lys Cys Met
Phe Lys Met Cys
Phe Met Cys Lys
Phe Met Cys Gln
Phe Met Lys Cys
Phe Met Gln Cys
Phe Gln Cys Met
Phe Gln Met Cys
Phe Arg Cys Cys
Gly Cys Trp Tyr
Gly Cys Tyr Trp
Gly Glu His Trp
Gly Glu Trp His
Gly His Glu Trp
Gly His Trp Glu
Gly Trp Cys Tyr
Gly Trp Glu His
Gly Trp His Glu
Gly Trp Tyr Cys
Gly Tyr Cys Trp
Gly Tyr Trp Cys
His Ala Asp Trp
His Ala Trp Asp
His Asp Ala Trp
His Asp Glu Lys
His Asp Glu Gln
His Asp Lys Glu
His Asp Gln Glu
His Asp Trp Ala
His Glu Asp Lys
His Glu Asp Gln
His Glu Glu Asn
His Glu Gly Trp
His Glu Lys Asp
His Glu Asn Glu
His Glu Gln Asp
His Glu Trp Gly
His Gly Glu Trp
His Gly Trp Glu
His Lys Asp Glu
His Lys Glu Asp
His Asn Glu Glu
His Gln Asp Glu
His Trp Ala Asp
His Trp Asp Ala
His Trp Glu Gly
His Trp Gly Glu
Lys Cys Asp Tyr
Lys Cys Phe Met
Lys Cys Met Phe
Lys Cys Tyr Asp
Lys Asp Cys Tyr
Lys Asp Glu His
Lys Asp His Glu
Lys Asp Tyr Cys
Lys Glu Asp His
Lys Glu His Asp
Lys Phe Cys Met
Lys Phe Met Cys
Lys His Asp Glu
Lys His Glu Asp
Lys Met Cys Phe
Lys Met Phe Cys
Lys Tyr Cys Asp
Lys Tyr Asp Cys
Met Cys Phe Lys
Met Cys Phe Gln
Met Cys Lys Phe
Met Cys Gln Phe
Met Phe Cys Lys
Met Phe Cys Gln
Met Phe Lys Cys
Met Phe Gln Cys
Met Lys Cys Phe
Met Lys Phe Cys
Met Asn Thr Tyr
Met Asn Tyr Thr
Met Gln Cys Phe
Met Gln Phe Cys
Met Gln Ser Tyr
Met Gln Tyr Ser
Met Ser Gln Tyr
Met Ser Tyr Gln
Met Thr Asn Tyr
Met Thr Tyr Asn
Met Tyr Asn Thr
Met Tyr Gln Ser
Met Tyr Ser Gln
Met Tyr Thr Asn
Asn Cys Glu Tyr
Asn Cys Tyr Glu
Asn Glu Cys Tyr
Asn Glu Glu His
Asn Glu His Glu
Asn Glu Tyr Cys
Asn His Glu Glu
Asn Met Thr Tyr
Asn Met Tyr Thr
Asn Thr Met Tyr
Asn Thr Tyr Met
Asn Tyr Cys Glu
Asn Tyr Glu Cys
Asn Tyr Met Thr
Asn Tyr Thr Met
Gln Cys Asp Tyr
Gln Cys Phe Met
Gln Cys Met Phe
Gln Cys Tyr Asp
Gln Asp Cys Tyr
Gln Asp Glu His
Gln Asp His Glu
Gln Asp Tyr Cys
Gln Glu Asp His
Gln Glu His Asp
Gln Phe Cys Met
Gln Phe Met Cys
Gln His Asp Glu
Gln His Glu Asp
Gln Met Cys Phe
Gln Met Phe Cys
Gln Met Ser Tyr
Gln Met Tyr Ser
Gln Ser Met Tyr
Gln Ser Tyr Met
Gln Tyr Cys Asp
Gln Tyr Asp Cys
Gln Tyr Met Ser
Gln Tyr Ser Met
Arg Cys Cys Phe
Arg Cys Phe Cys
Arg Cys Ser Tyr
Arg Cys Tyr Ser
Arg Phe Cys Cys
Arg Ser Cys Tyr
Arg Ser Tyr Cys
Arg Tyr Cys Ser
Arg Tyr Ser Cys
Ser Cys Arg Tyr
Ser Cys Tyr Arg
Ser Met Gln Tyr
Ser Met Tyr Gln
Ser Gln Met Tyr
Ser Gln Tyr Met
Ser Arg Cys Tyr
Ser Arg Tyr Cys
Ser Tyr Cys Arg
Ser Tyr Met Gln
Ser Tyr Gln Met
Ser Tyr Arg Cys
Thr Met Asn Tyr
Thr Met Tyr Asn
Thr Asn Met Tyr
Thr Asn Tyr Met
Thr Tyr Met Asn
Thr Tyr Asn Met
Trp Ala Asp His
Trp Ala His Asp
Trp Cys Gly Tyr
Trp Cys Tyr Gly
Trp Asp Ala His
Trp Asp His Ala
Trp Glu Gly His
Trp Glu His Gly
Trp Gly Cys Tyr
Trp Gly Glu His
Trp Gly His Glu
Trp Gly Tyr Cys
Trp His Ala Asp
Trp His Asp Ala
Trp His Glu Gly
Trp His Gly Glu
Trp Tyr Cys Gly
Trp Tyr Gly Cys
Tyr Cys Asp Lys
Tyr Cys Asp Gln
Tyr Cys Glu Asn
Tyr Cys Gly Trp
Tyr Cys Lys Asp
Tyr Cys Asn Glu
Tyr Cys Gln Asp
Tyr Cys Arg Ser
Tyr Cys Ser Arg
Tyr Cys Trp Gly
Tyr Asp Cys Lys
Tyr Asp Cys Gln
Tyr Asp Lys Cys
Tyr Asp Gln Cys
Tyr Glu Cys Asn
Tyr Glu Asn Cys
Tyr Gly Cys Trp
Tyr Gly Trp Cys
Tyr Lys Cys Asp
Tyr Lys Asp Cys
Tyr Met Asn Thr
Tyr Met Gln Ser
Tyr Met Ser Gln
Tyr Met Thr Asn
Tyr Asn Cys Glu
Tyr Asn Glu Cys
Tyr Asn Met Thr
Tyr Asn Thr Met
Tyr Gln Cys Asp
Tyr Gln Asp Cys
Tyr Gln Met Ser
Tyr Gln Ser Met
Tyr Arg Cys Ser
Tyr Arg Ser Cys
Tyr Ser Cys Arg
Tyr Ser Met Gln
Tyr Ser Gln Met
Tyr Ser Arg Cys
Tyr Thr Met Asn
Tyr Thr Asn Met
Tyr Trp Cys Gly
Tyr Trp Gly Cys
Benflumetol
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Pirozadil
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98151 - Niacin-based Antilipidemic Agent
Benzenepropanoic acid, 4-[[4-(4-methoxyphenyl)-5-[4-(trifluoromethyl)phenyl]-2-thiazolyl]methoxy]-2-methyl-
Barnidipine
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
5(6)-CARBOXYTETRAMETHYLRHODAMINE N-SUCCINIMIDYL ESTER
Hydro-tris(3-phenylpyrazol-1-yl)borate potassium salt
5(6)-TAMRA, SE [5-(and-6)-Carboxytetramethylrhodamine, succinimidyl ester]
(E)-1-(5-((E)-(3-Fluorodibenzo(b,E)oxepin-11(6H)-ylidene)methyl)-1-((R)-1-morpholinopropan-2-yl)-1H-benzo(d)imidazol-2(3H)-ylidene)urea
(R)-2-(3-(3-(4-methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl)phenoxy)butanoic acid
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(2-pyridinyl)-4-quinolinecarboxamide
Lumefantrine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
(1S,3R,4R)-3-ethyl-3,4,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranoside
(3aS,4S,4R,5S,6R,7S,7aS)-4-[(1R,2S,3R,5S,6R)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6-[(1R)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2-oxane]-3,4,5,7-tetrol
2-(dibutylamino)-1-{2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl}ethan-1-ol
Hygromycin B
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
(7S,9S)-9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(3-pyridinyl)-4-quinolinecarboxamide
[4-({3-[2-(1H-indol-3-yl)ethyl]-2-[(4-methoxyphenyl)imino]-4-oxo-1,3-thiazolidin-5-ylidene}methyl)phenoxy]acetic acid
(7R,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
2-[(1S,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
(2R,4S)-4-[[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]methyl]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-2-carboxylic acid
2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1R,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
[(1R)-2-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-phenylmethanone
alpha-L-Fucp-(1->3)-[4d-beta-D-Galp-(1->4)]-beta-D-GlcpNAc-OMe
N3-[4-(difluoromethoxy)phenyl]-1-(3,4-dimethylphenyl)-N7-(2-hydroxyethyl)-2-mercaptoimidazo[1,2-a]pyridin-4-ium-3,7-dicarboxamide
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1,3-dihydroxy-2-pentyl-1-phenylpropan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2,3-dihydroxy-2-pentyl-1-phenylpropyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
Antihelmycin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
Destomysin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
11-deoxy-beta-rhodomycin zwitterion
A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of 11-deoxy-beta-rhodomycin; major species at pH 7.3.
9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
11-Deoxy-beta-rhodomycin
A member of the class of anthracyclines that is beta-rhodomycin lacking the phenolic hydroxy group at position 11.
4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp zwitterion
An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp.
Beperidium iodide
Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93.
Rapastinel (Trifluoroacetate)
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate) is an NMDA receptor modulator with glycine-site partial agonist properties. Rapastinel Trifluoroacetate has the potential for major depressive disorder treatment.
1-(3-hydroperoxy-3-methylbut-1-en-1-yl)-3',4'-dihydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecane]-2,2',8'-trione
(8s,10s)-10-{[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,8,11-tetrahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
(7s,8s,10r)-10-{[(2s,4r,5r,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8-tetrahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
7-{[(2s,4s,5s,6s)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,8,10-tetrahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
(1r,2z,6z,10e)-3-formyl-7,11-dimethylcyclododeca-2,6,10-trien-1-yl 6-nitro-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylate
aristoloterpenate i; 8-demethoxy
{"Ingredient_id": "HBIN016834","Ingredient_name": "aristoloterpenate i; 8-demethoxy","Alias": "NA","Ingredient_formula": "C31H29NO7","Ingredient_Smile": "NA","Ingredient_weight": "527.56","OB_score": "NA","CAS_id": "222403-62-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6648","PubChem_id": "NA","DrugBank_id": "NA"}
aristoloterpenate i; 8-demethoxy,2'e-isomer
{"Ingredient_id": "HBIN016835","Ingredient_name": "aristoloterpenate i; 8-demethoxy,2'e-isomer","Alias": "NA","Ingredient_formula": "C31H29NO7","Ingredient_Smile": "NA","Ingredient_weight": "527.56","OB_score": "NA","CAS_id": "222403-63-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6647","PubChem_id": "NA","DrugBank_id": "NA"}
aristophyllide a; 5',12'-diepimer,demethoxy
{"Ingredient_id": "HBIN016840","Ingredient_name": "aristophyllide a; 5',12'-diepimer,demethoxy","Alias": "NA","Ingredient_formula": "C31H29NO7","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6644","PubChem_id": "NA","DrugBank_id": "NA"}
aristophyllide a; demethoxy
{"Ingredient_id": "HBIN016841","Ingredient_name": "aristophyllide a; demethoxy","Alias": "NA","Ingredient_formula": "C31H29NO7","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6643","PubChem_id": "NA","DrugBank_id": "NA"}